By Josh White
Date: Monday 26 Feb 2024
(Sharecast News) - Infection prevention products developer Tristel announced the successful conclusion of all reviews required under the UK and European Union medical devices regulations for the approval of its TANK ClO2 sporicidal disinfectant system on Monday.
By Josh White
Date: Tuesday 19 Dec 2023
(Sharecast News) - Infection prevention products developer Tristel flagged a record-breaking first half in an update on Tuesday, with expected revenues of £20.7m for the six months ending 31 December.
By Benjamin Chiou
Date: Monday 16 Oct 2023
(Sharecast News) - AIM-listed Tristel saw profits jump by over a third in the year to 30 June after smashing its internal growth targets, and said it has started shipping products to its first customers in the US after a recent FDA approval.
Currency | UK Pounds |
Share Price | 465.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 485.00 |
52 Week Low | 327.50 |
Volume | 47,689 |
Shares Issued | 47.49m |
Market Cap | £220.85m |
RiskGrade | 180 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 21-Mar-24 | 23-Nov-23 |
Paid | 12-Apr-24 | 22-Dec-23 |
Amount | 5.24p | 7.88p |
Time | Volume / Share Price |
15:56 | 20,000 @ 451.00p |
16:26 | 1,500 @ 460.00p |
16:23 | 2 @ 470.00p |
15:39 | 233 @ 463.45p |
15:36 | 2,500 @ 463.00p |
CEO | Paul Christopher Swinney |
Finance Director | Elizabeth Dixon |
You are here: research